Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | STX-478 |
Trade Name | |
Synonyms | STX 478|STX478 |
Drug Descriptions |
STX-478 inhibits PIK3CA H1047 mutations, potentially resulting in decreased tumor cell proliferation and reduced tumor growth (Cancer Res 2023;83(5 Suppl):Abstract nr P4-07-04). |
DrugClasses | PIK3CA inhibitor 24 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Fulvestrant + STX-478 | Fulvestrant STX-478 | 0 | 1 |
Palbociclib + STX-478 | Palbociclib STX-478 | 0 | 0 |
STX-478 | STX-478 | 10 | 1 |